• SPECIALTY
  • PROVIDER INFO
  • EDUCATION
  • AFFILIATIONS
  • RESEARCH & PUBLICATIONS
  • ACHIEVEMENTS
  • PATIENT RATINGS & COMMENTS

Office locations

Los Angeles
Los Angeles
Samuel Oschin Cancer Center
3104235776
127 S San Vicente Blvd - 7th Floor
Los Angeles
CA
90048
3104235776
8700 Beverly Bl #AC-1042-B
Los Angeles
CA
90048

Specialty

  • IM/Hematology/Oncology

    Provider Info

    GENDER

    Male

    LANGUAGES

    Cantonese, Spanish, English

    EXPERIENCE

    13 years

    Education

    • City of Hope Comprehensive Cancer Center
      Fellowship - Completed 2015
    • Cedars-Sinai
      Residency - Completed 2013
    • Cedars-Sinai
      Internship - Completed 2012
    • New York Medical College
      Medical School - Completed 2008

    Research

    Jun Gong, MD, is a medical oncologist of the Gastrointestinal Disease Research Group, Pancreatic Cancer Research Group, and Urologic Oncology Program in the Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai. His primary clinical interests are in gastrointestinal (GI), hepatobiliary, and genitourinary (GU) cancers with a multidisciplinary focus of care along with colleagues from surgery, gastroenterology, radiation oncology, radiology, and urology. Dr. Gong is focused on translational and clinical cancer research with interests in early therapeutic trials (immunotherapy, targeted therapies, biologics, and other systemic therapies) and biomarker development to improve patient outcomes in GI and GU cancers

    PUBLICATIONS

    • Wang C, Gong J, Tu TY, Lee PP, Fakih M. Immune profiling of microsatellite instability-high and polymerase ε (POLE)-mutated metastatic colorectal tumors identifies predictors of response to anti-PD-1 therapy. J Gastrointest Oncol. 2018 Jun;9(3):404-415.
    • Gong J, Omlin A, Pal SK, Hsu J, Tombal B, Sydes MR, Gillessen S. Influence of an International Consensus Conference on Practice Patterns in Advanced Prostate Cancer. Eur Urol. 2018 Aug;74(2):239-240.
    • Cho M1 Gong J, Frankel P, Synold TW, Lim D, Chung V, Chao J, Li D, Chen Y, Sentovich S, et al. A phase I clinical trial of binimetinib in combination with FOLFOX in patients with advanced metastatic colorectal cancer who failed prior standard therapy. Oncotarget. 2017 Jul 18;8(45):79750-79760.
    • Gong J, Chen Y, Yang L, Pillai R, Shirasawa S, Fakih M. MEK162 Enhances Antitumor Activity of 5-Fluorouracil and Trifluridine in KRAS-mutated Human Colorectal Cancer Cell Lines. Anticancer Res. 2017 Jun;37(6):2831-2838.
    more

    Achievements

    Board Certifications

    • Board Certified in Hematology
    • Board Certified in Internal Medicine
    • Board Certified in Medical Oncology

    Awards & Activities

    • ASCO/AACR Workshop on Methods in Clinical Cancer Research - 2017
    • NCCN Oncology Fellows Program - 2017
    • Young Investigator’s Think Tank, 15th International Kidney Cancer Symposium, Kidney Cancer Association - 2016
    • Travel Award, 15th International Kidney Cancer Symposium, Kidney Cancer Association - 2016
    more

    Patient Ratings & Comments Learn more

    Ratings

    Average Rating:
    4.9 / 5
    209 Ratings

    Rating Breakdown

    five star (193):
    four star (14):
    three star (0):
    two star (0):
    one star (2):

    Comments

    By Cedars-Sinai Patienton Mar 24, 2021

    Dr. Gong was extremely knowledgeable and a very caring individual. We truly appreciated his insight and knowledge regarding my husbands situation

    By Cedars-Sinai Patienton Mar 16, 2021

    Ohh, hi, I was great. This is the only thing I can think of is that I was told by a previous doctors that I would also need to visit with a radio oncologist, but I was only scheduled with Dr. Gong first and then it was only the day after I met with Dr. Gong that I got the referral to the radio oncologist and scheduled with him and that delay caused an extra week allowing cancer to party on and so it would be really great. If you know if his team could have seen that I also need to see the radio oncologist and could have started that booking process even before my appointment so that we didn't have to have that further when we delay.

    By Cedars-Sinai Patienton Mar 15, 2021

    Excellent

    more